GlobeNewswire Inc.··NaBiofrontera to Report Q1 2026 Results as PDT Expansion Accelerates
Biofrontera to report Q1 2026 results May 14, advancing Ameluz® commercialization and clinical expansion into skin cancers and acne.
BFRIBFRIWclinical trialsbiopharmaceutical